Drug-development United States

Established in 1995, MacroMed is a specialty biopharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing its proprietary polymer technologies. MacroMed collaborates with major pharmaceutical and biotechnology ...

Covance Inc. is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. The Company also provides ...

Hydra Biosciences, a biopharmaceutical company, develops novel drugs using its expertise in ion channels. The company is currently focused in major therapeutic areas: pain, inflammation, renal, cardiovascular and pulmonary disease. Hydra's mission is to ...

RxKinetix, Inc. is a specialty pharmaceutical company developing new therapeutics focused in oncology care. Using proven pharmaceuticals and proprietary polymer-based drug delivery technologies, RxKinetix creates new drugs or enhances existing drugs. The ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

ICOS is a product-driven company that has expertise in both protein-based and small molecule therapeutics. ICOS combines its capabilities in molecular, cellular and structural biology, high throughput drug screening, medicinal chemistry and gene expression ...

At ILEX, we continue to research and acquire compounds with unique mechanisms of action, targeting novel receptors. We are focused on building a portfolio of oncology compounds that are different than those already available to patients and that provide ...

Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal disorders and diseases. The ...

ICOS is a product-driven company that has expertise in both protein-based and small molecule therapeutics. ICOS combines its capabilities in molecular, cellular and structural biology, high throughput drug screening, medicinal chemistry and gene expression ...

At ILEX, we continue to research and acquire compounds with unique mechanisms of action, targeting novel receptors. We are focused on building a portfolio of oncology compounds that are different than those already available to patients and that provide ...

Endovasc, Inc. is a business development company focused on drug development in the areas of cardiovascular and metabolic medicine. The Company’s licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

Commonwealth Biotechnologies, Inc. (CBI) is a specialized life sciences outsourcing business that offers expertise and a complete range of discovery chemistry and biology products and services, through its subsidiary companies. The subsidiaries of the ...

"Bone Care International, Inc. is an innovative pharmaceutical company dedicated to improving patient outcomes by delivering unsurpassed Vitamin D hormone therapies. Bone Care International, Inc. is committed to discovering, developing and commercializing ...

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals ...

Accium provides a portfolio of AMS-based bioanalytical services that address challenging problems in drug development. Our preclinical and clinical development services help to answer critical questions associated with drug bioavailability, pharmacokinetics ...

RxElite Holdings, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics ...

Alnis is currently developing proprietary MagNaGel nanoparticles that combine diagnostic, drug and device capabilities to better detect, characterize and treat cancer. MagNaGel nanoparticles approximate the size and tumor-targeting capabilities of monoclonal ...

Astellas Pharma Inc is a Japan-based company engaged in the manufacturing and sale of pharmaceuticals and related products. The Company offers its pharmaceuticals to both domestic and overseas markets including Japan, North America, Europe and Asia. In ...

CoTherix, Inc. is committed to provide pulmonary arterial hypertension (PAH) patients with rapid access to Ventavis® (iloprost) Inhalation Solution, recently approved by the U.S. Food and Drug Administration for the treatment of PAH (WHO Group I) in patients ...

Novelos Therapeutics, Inc. (OTCBB: NVLT) is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of Cancer and Hepatitis. NOV-002, the lead compound in Phase 3 development for lung cancer under a Special Protocol ...

NanoCor Therapeutics, Inc. ("NanoCor") is a biotechnology company founded to create the first viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure ("CHF"). The company was spun off from Asklêpios BioPharmaceutical, Inc ...

OctoPlus N.V. is a Netherlands-based drug delivery and development company that maintains partnerships with large and small biotech and pharma companies globally. The Company's business activities include pharmaceutical development services, drug delivery ...

Cypress Bioscience, Inc. is developing milnacipran for fibromyalgia (FM). In March 2008, the Company completed the acquisition of Proprius Pharmaceuticals, Inc. (Proprius), to include providing personalized medicine laboratory services to rheumatologists ...

HELSINN HEALTHCARE SA is a privately owned pharmaceutical group with headquarters in Switzerland and is the worldwide licensor of palonosetron. HELSINN's core business is the licensing of pharmaceuticals in therapeutic niche areas. The company's business ...